Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: June 18, 2025
Reverse Bernheim Phenomenon - A True Enigma.
Journal: Respiratory medicine case reports
Published: December 16, 2024
The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series.
Journal: American heart journal plus : cardiology research and practice
Published: November 29, 2024
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis.
Journal: American journal of physiology. Cell physiology
Published: November 07, 2024
Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies.
Journal: Pulmonary therapy
Published: October 16, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Journal: The European respiratory journal
Published: December 15, 2022
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Journal: Pulmonary circulation
Published: December 09, 2021
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Journal: Pulmonary circulation
Published: October 15, 2021
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Journal: Pulmonary circulation
Published: July 13, 2021
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: July 11, 2021
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily.
Journal: Pulmonary circulation
Published: May 24, 2021
Last Updated: 09/26/2026